Expression of bone turnover markers in patients with tuboovarian carcinoma exposed to platinum-based chemotherapy ± bevacizumab

被引：0
|
作者：
Kurbacher, C. M. [1 ]
Huhmann, A. [1 ]
Herz, S. [1 ]
Kurbacher, A. T. [1 ]
Monreal, K. [1 ]
Kurbacher, J. A. [2 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Gynecol Oncol, Bonn, Germany
[2] Gynecol Ctr Bonn Friedenspl, Gen Gynecol & Obstet, Bonn, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-0268
引用
收藏
页码：750 / 750
页数：1
相关论文
共 50 条
  • [41] THE ASSOCIATION BETWEEN EXPRESSION OF TBX2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA
    Tasaka, R.
    Fukuda, T.
    Inoue, Y.
    Shimomura, M.
    Matsubara, H.
    Wada, T.
    Kawanishi, M.
    Yasui, T.
    Sumi, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 287 - 287
  • [42] THE ASSOCIATION BETWEEN EXPRESSION OF UCP2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA
    Kawanishi, M.
    Fukuda, T.
    Inoue, Y.
    Shimomura, M.
    Matsubara, H.
    Wada, T.
    Tasaka, R.
    Yasui, T.
    Sumi, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1495 - 1495
  • [43] THE ASSOCIATION BETWEEN EXPRESSION OF UCP2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA
    Kawanishi, M.
    Fukuda, T.
    Inoue, Y.
    Shimomura, M.
    Matsubara, H.
    Wada, T.
    Tasaka, R.
    Yasui, T.
    Sumi, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 288 - 288
  • [44] Bevacizumab combined with platinum-based chemotherapy in primary or relapsed ovarian cancer patients: Meta-analysis and literature to review
    Tauseef, Abubakar
    Zafar, Maryam
    Abodunrin, Faith
    Siddiqui, Sameed A. H.
    Millner, Paul
    Khan, Saber M.
    Teplitsky, Ella
    Masih, Durva
    Mirza, Muazzam
    Mirza, Mohsin
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (11) : 2797 - 2804
  • [45] The prognostic impact of bone metastasis in urothelial carcinoma treated with first-line platinum-based chemotherapy.
    Alqaisi, Husam
    Veitch, Zachary William Neil
    Stecca, Carlos
    Kaiser, Jeenan
    North, Scott A.
    Samnani, Sunil
    Alimohamed, Nimira S.
    Sridhar, Srikala S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [46] Bevacizumab Plus Platinum-Based Chemotherapy In Advanced Non-Small Cell Lung Cancer
    Wagstaff, Antona J.
    Keam, Susan J.
    McCormack, Paul L.
    BIODRUGS, 2009, 23 (03) : 187 - 196
  • [47] Feasibility and effectiveness of multiple lines of bevacizumab-based therapy in patients with recurrent tuboovarian carcinoma
    Kallage, V.
    Kurbacher, A. T.
    Herz, S.
    Kolberg, G.
    Schweitzer, C.
    Kurbacher, J. A.
    Kurbacher, C. M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] EFFICACY AND SAFETY OF FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH POST-OPERATIVE RECURRENCE AFTER PLATINUM-BASED ADJUVANT CHEMOTHERAPY
    Muraki, K.
    Imai, H.
    Shukuya, T.
    Ohhashi, R.
    Koyama, R.
    Mori, T.
    Murakami, H.
    Takahashi, T.
    Yamamoto, N.
    Takahashi, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 148 - 148
  • [49] Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer
    Wimberger, Pauline
    Heubner, Martin
    Otterbach, Friedrich
    Fehm, Tanja
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 331 - 338
  • [50] Role of adjunctive surgery after platinum-based chemotherapy in management patients with adrenocortical carcinoma: Observation study
    Zhulikov, Y. A.
    Kovalenko, E. I.
    Artamonova, E.
    Evdokimova, E. V.
    Bohian, V.
    Gabrava, M.
    Kolobanova, E.
    Yugay, V. V.
    Stilidi, I. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S537 - S537
12345